IL6 and COVID-19: In a previous work, enhanced gut microbiota levels of Pyramidobacter correlated with circulating IL-6 levels, an upstream regulator of the pro-inflammatory response in severe COVID-19 disease, and predictor of disease progression in frail adults [14] while enriched Olsenella were detected in the lung microbiota of COVID-19 patients [15].